- Home
- BTAI vs MODD Comparison
BTAI vs MODD Comparison
Compare BTAI & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- MODD
- Stock Information
- Founded
- BTAI 2017
- MODD 1998
- Country
- BTAI United States
- MODD United States
- Employees
- BTAI N/A
- MODD N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- BTAI Health Care
- MODD Health Care
- Exchange
- BTAI Nasdaq
- MODD Nasdaq
- Market Cap
- BTAI 52.7M
- MODD 46.3M
- IPO Year
- BTAI 2018
- MODD N/A
- Fundamental
- Price
- BTAI $3.01
- MODD $0.75
- Analyst Decision
- BTAI Buy
- MODD
- Analyst Count
- BTAI 5
- MODD 0
- Target Price
- BTAI $32.80
- MODD N/A
- AVG Volume (30 Days)
- BTAI 5.2M
- MODD 1.2M
- Earning Date
- BTAI 11-13-2025
- MODD 11-13-2025
- Dividend Yield
- BTAI N/A
- MODD N/A
- EPS Growth
- BTAI N/A
- MODD N/A
- EPS
- BTAI N/A
- MODD N/A
- Revenue
- BTAI $868,000.00
- MODD N/A
- Revenue This Year
- BTAI N/A
- MODD N/A
- Revenue Next Year
- BTAI $614.78
- MODD N/A
- P/E Ratio
- BTAI N/A
- MODD N/A
- Revenue Growth
- BTAI N/A
- MODD N/A
- 52 Week Low
- BTAI $1.17
- MODD $0.63
- 52 Week High
- BTAI $13.28
- MODD $2.50
- Technical
- Relative Strength Index (RSI)
- BTAI 41.66
- MODD 53.37
- Support Level
- BTAI $2.86
- MODD $0.65
- Resistance Level
- BTAI $3.95
- MODD $1.00
- Average True Range (ATR)
- BTAI 0.34
- MODD 0.06
- MACD
- BTAI -0.17
- MODD 0.00
- Stochastic Oscillator
- BTAI 11.89
- MODD 24.28
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.